If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where masaki shiota is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 7 Similar Profiles
Prostatic Neoplasms Medicine & Life Sciences
Castration Medicine & Life Sciences
Androgen Receptors Medicine & Life Sciences
Androgens Medicine & Life Sciences
docetaxel Medicine & Life Sciences
Y-Box-Binding Protein 1 Medicine & Life Sciences
Urinary Bladder Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2003 2019

1 Citation (Scopus)

Association of Missense Polymorphism in HSD3B1 With Outcomes Among Men With Prostate Cancer Treated With Androgen-Deprivation Therapy or Abiraterone

shiota, M., Narita, S., Akamatsu, S., Fujimoto, N., Sumiyoshi, T., Fujiwara, M., Uchiumi, T., Habuchi, T., Ogawa, O. & Eto, M., Feb 1 2019, In : JAMA network open. 2, 2, p. e190115

Research output: Contribution to journalArticle

Open Access
Androgens
Prostatic Neoplasms
Odds Ratio
Therapeutics
Castration
Androgen Antagonists
Androgen Receptors
docetaxel
Prostatic Neoplasms
Smoking

Efficacy and safety of 4-weekly cabazitaxel for castration-resistant prostate cancer: a multi-institutional study

shiota, M., Nakamura, M., Yokomizo, A., Tomoda, T., Sakamoto, N., Seki, N., Hasegawa, S., Yunoki, T., Harano, M., Kuroiwa, K. & Eto, M., Sep 1 2019, In : Cancer chemotherapy and pharmacology. 84, 3, p. 561-566 6 p.

Research output: Contribution to journalArticle

Castration
Prostatic Neoplasms
Hazards
Safety
Confidence Intervals

Efficacy and safety of cabazitaxel for castration-resistant prostate cancer in patients with > 10 cycles of docetaxel chemotherapy: a multi-institutional study

shiota, M., Nakamura, M., Yokomizo, A., Tomoda, T., Sakamoto, N., Seki, N., Hasegawa, S., Yunoki, T., Harano, M., Kuroiwa, K. & Eto, M., Apr 1 2019, In : Medical Oncology. 36, 4, 32.

Research output: Contribution to journalArticle

docetaxel
Castration
Prostatic Neoplasms
Safety
Drug Therapy

Establishment of precision medicine in pharmacotherapy for castration-resistant prostate cancer

shiota, M. & Eto, M., Apr 1 2019, In : Nishinihon Journal of Urology. 81, 2, p. 155-160 6 p.

Research output: Contribution to journalArticle

Precision Medicine
Castration
Prostatic Neoplasms
Drug Therapy
docetaxel